Literature DB >> 24296579

Faecal microbiota transplantation in 2013: developing human gut microbiota as a class of therapeutics.

Alexander Khoruts1.   

Abstract

Although the idea of faecal transplantation dates back many decades, only with advances in scientific technologies can we begin systematic development of this new class of therapeutics. The primary focus remains on treatment of Clostridium difficile infection—new applications are beginning to emerge, but a long journey remains ahead.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24296579     DOI： 10.1038/nrgastro.2013.231

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  4 in total

1.  Functional Gut Microbiota Remodeling Contributes to the Caloric Restriction-Induced Metabolic Improvements.

Authors:  Salvatore Fabbiano; Nicolas Suárez-Zamorano; Claire Chevalier; Vladimir Lazarević; Silas Kieser; Dorothée Rigo; Stefano Leo; Christelle Veyrat-Durebex; Nadia Gaïa; Marcello Maresca; Doron Merkler; Mercedes Gomez de Agüero; Andrew Macpherson; Jacques Schrenzel; Mirko Trajkovski
Journal:  Cell Metab       Date:  2018-08-30       Impact factor: 27.287

Review 2.  Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review).

Authors:  Qingchun Lei; Tingting Wu; Jin Wu; Xiaogang Hu; Yingxia Guan; Ying Wang; Jinyuan Yan; Guolin Shi
Journal:  Mol Med Rep       Date:  2021-08-20       Impact factor: 2.952

3.  Rural and urban microbiota: To be or not to be?

Authors:  Alexander V Tyakht; Dmitry G Alexeev; Anna S Popenko; Elena S Kostryukova; Vadim M Govorun
Journal:  Gut Microbes       Date:  2014-04-01

Review 4.  Human Gut Microbiota: Toward an Ecology of Disease.

Authors:  Susannah Selber-Hnatiw; Belise Rukundo; Masoumeh Ahmadi; Hayfa Akoubi; Hend Al-Bizri; Adelekan F Aliu; Tanyi U Ambeaghen; Lilit Avetisyan; Irmak Bahar; Alexandra Baird; Fatema Begum; Hélène Ben Soussan; Virginie Blondeau-Éthier; Roxane Bordaries; Helene Bramwell; Alicia Briggs; Richard Bui; Matthew Carnevale; Marisa Chancharoen; Talia Chevassus; Jin H Choi; Karyne Coulombe; Florence Couvrette; Samantha D'Abreau; Meghan Davies; Marie-Pier Desbiens; Tamara Di Maulo; Sean-Anthony Di Paolo; Sabrina Do Ponte; Priscyla Dos Santos Ribeiro; Laure-Anne Dubuc-Kanary; Paola K Duncan; Frédérique Dupuis; Sara El-Nounou; Christina N Eyangos; Natasha K Ferguson; Nancy R Flores-Chinchilla; Tanya Fotakis; Mariam Gado Oumarou H D; Metodi Georgiev; Seyedehnazanin Ghiassy; Natalija Glibetic; Julien Grégoire Bouchard; Tazkia Hassan; Iman Huseen; Marlon-Francis Ibuna Quilatan; Tania Iozzo; Safina Islam; Dilan B Jaunky; Aniththa Jeyasegaram; Marc-André Johnston; Matthew R Kahler; Kiranpreet Kaler; Cedric Kamani; Hessam Karimian Rad; Elisavet Konidis; Filip Konieczny; Sandra Kurianowicz; Philippe Lamothe; Karina Legros; Sebastien Leroux; Jun Li; Monica E Lozano Rodriguez; Sean Luponio-Yoffe; Yara Maalouf; Jessica Mantha; Melissa McCormick; Pamela Mondragon; Thivaedee Narayana; Elizaveta Neretin; Thi T T Nguyen; Ian Niu; Romeo B Nkemazem; Martin O'Donovan; Matthew Oueis; Stevens Paquette; Nehal Patel; Emily Pecsi; Jackie Peters; Annie Pettorelli; Cassandra Poirier; Victoria R Pompa; Harshvardhan Rajen; Reginald-Olivier Ralph; Josué Rosales-Vasquez; Daria Rubinshtein; Surya Sakr; Mohammad S Sebai; Lisa Serravalle; Fily Sidibe; Ahnjana Sinnathurai; Dominique Soho; Adithi Sundarakrishnan; Veronika Svistkova; Tsolaye E Ugbeye; Megan S Vasconcelos; Michael Vincelli; Olga Voitovich; Pamela Vrabel; Lu Wang; Maryse Wasfi; Cong Y Zha; Chiara Gamberi
Journal:  Front Microbiol       Date:  2017-07-17       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.